BioAmber joins NYX markets in Europe and US

Listing has raised a total of approximately €62 million/$80 million.

BioAmber Inc, a sustainable chemicals company, celebrated its first day of trading as a dual listed company on NYSE Euronext (NYX) markets in Europe and the United States this week by ringing the Opening Bell in Paris.

Founded in 2008, BioAmber is a sustainable chemicals company. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable raw materials into sustainable chemicals, thereby replacing petrochemicals in a wide variety of everyday products ranging from plastics to personal care products. BioAmber currently produces succinic acid in Pomacle, France, at one of the largest bio-based chemical manufacturing facilities in the world for biosourced chemical products. With the proceeds from the offering, BioAmber plans to build a worldscale bio-succinic acid manufacturing facility in Sarnia with 30,000 ton annual capacity.

BioAmber began trading on the New York Stock Exchange (NYSE) on 10 May 2013 and on the professional segment of NYSE Euronext in Paris today through a public offering in the United States. The listing raised a total of approximately €62 million/$80 million.

The final offering price of BioAmber was set at €7.6/$10 per share on May 10. Market capitalisation stood at around €138 million/$180 million on the day of listing.

Jean-François Huc, CEO of BioAmber, commented “ This IPO allows investors access for trading in US dollars and Euros on either market, and the dual listing more accurately reflects our business model, which targets the global chemical supply chain and is anchored in both Europe and North America..”

Scott Cutler, EVP, Head of Global Listings at NYSE Euronext, added “We are very pleased to welcome BioAmber as it enters a new phase in its development. This major listing reconfirms NYSE Euronext’s role as a pacesetter for cleantech shares, offering optimum visibility and outstanding access to investors from around the world.”

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

WHAT IS ADVFN?

ADVFN covers all things stock market.

From the news and opinion pieces on pages like this to share discussion forums, charting tools, financials, live share prices and Level 2, order book data

If you trade or invest ADVFN has the tools you need to make the right decisions.

• 

  101 Ways to Pick Stock Market Winners

  You need the number one bestselling investment guide, the definitive text for day traders, investors and stock pickers.

• 

  The Death of Wealth

  Dissecting the global economy and the financial markets, the book lays out the evidence for the next economic game changer: the Death of Wealth.

• 

  Matthew Davison

• 

  Clem Chambers

• 

  Luca Rossi

• 

  Matt Simpson